Developer docs
API playgroundTry for free, no card

Search company profiles

LynxCare

Full company profile

uuid0000yq4

Namestring
LynxCare
Legal namestring
LynxCare Clinical Informatics NV
Websiteurl
lynx.care
Company typeenum
Private
Founded yearint
2015
Descriptiontext

LynxCare Clinical Informatics NV is a Belgian-headquartered health-data company founded in 2015 that operates a federated clinical data platform purpose-built for hospitals and life sciences organizations. Its core technology combines a proprietary clinical Natural Language Processing (cNLP) pipeline — built on healthcare-trained small language models rather than generic LLMs — with OMOP Common Data Model harmonization and a federated-by-design architecture in which analytics and model execution occur where the patient data resides, ensuring hospitals retain custody of raw data and that the system is GDPR-compliant by default. The platform extracts structured, analysis-ready clinical concepts (diagnoses, symptoms, procedures, medications, outcomes) from unstructured EHR narrative text, complements this with structured-field processing, and subjects outputs to a five-layer Sentinel data quality framework (conformance, completeness, plausibility, medical review, benchmark). External validation has demonstrated 94% precision and 88% recall on cancer registry data, outperforming QuickUMLS, Mistral 7B, and SapBERT on multilingual clinical narratives.

The commercial offering is built around pre-built longitudinal real-world data assets spanning oncology, cardiology, and mental health — covering 124,500+ patients across Immuno-Oncology (5,000+), Lung Cancer (14,000+), Breast Cancer (20,000+), CLL (2,500+), Multiple Myeloma (2,500+), Heart Failure (44,000+), aTTR-CM (1,500+), and Mental Health (35,000+) — with 45–80% of endpoints NLP-enriched. Supporting services include feasibility assessments for prospective RWE studies and a structured six-step data partner onboarding process for new hospitals. The company serves two primary customer segments: hospitals seeking to participate in multi-center research, improve quality control, and unlock value from their EHR data; and life sciences organizations (pharma, biotech, medical device companies) needing regulatory-grade real-world evidence for clinical development, regulatory submissions, and post-market surveillance. Go-to-market is enterprise field sales with a quote-based, multi-year subscription model, active across Belgium, the Netherlands, France, and Germany, with an October 2024 partnership with Dedalus extending channel reach and a February 2026 entry into the OncoLab consortium deepening oncology research positioning.

LynxCare has raised approximately €26M cumulatively across multiple funding rounds, with the €20M Series A in June 2022 (led by MTIP, joined by Elaia, Heran Partners, Btov Partners, and PMV) being the largest Belgian digital health round at the time. The company employs 30+ multidisciplinary staff and is led by CEO Mikaela Bruhammar, Co-founder and CMO Dries Hens, CTPO Tom Dufour, with CCO Rhiannon Thomason (Jan 2026), General Counsel Bram Van Eeckhout, and former Sanofi CSO Laurent van Lerberghe as board advisor (Feb 2024). Its compliance stack includes ISO/IEC 27001:2022, NEN 7510, GDPR with appointed DPO, HIPAA, and EHDEN Certified SME Partner status.

Short descriptiontext

LynxCare operates a federated clinical data platform that uses proprietary NLP to convert European hospital EHRs into OMOP-compliant, quality-validated real-world evidence. It serves hospitals seeking research participation and life sciences organizations requiring regulatory-grade datasets across oncology, cardiology, and mental health.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLeuven, Belgium
HQ citystring
Leuven
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical data platform, real-world evidence, clinical NLP, federated analytics, EHR data harmonization
Industry4 codes
PRIMARYHLACAIAF
Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACABAJ
Terminology Services & Semantic Interoperability (SNOMED/LOINC/RxNorm mapping)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLAJAJAM
Data Governance, Standards & Interoperability (ICD, HL7/FHIR, LOINC, SNOMED)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics
SECONDARYHLACAIAH
Clinical Data Repositories (CDR) & Longitudinal Patient Records
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
NAICS code1 code
  • Services for the Elderly and Persons with Disabilities624120
SIC code1 code
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Healthcare Data Analytics / Real-World Evidence Platform
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Real-World Evidence Platform Services
TypeSubscription Recurring
Description

Provides clinical NLP-enriched EHR data, federated analytics, and data quality services to hospitals and life sciences organizations. Revenue likely derived from subscription-based contracts with healthcare organizations for access to the data platform and insights.

lynx.care
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise subscription contracts
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed

lynx.care
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

LynxCare provides a federated clinical data platform that uses proprietary clinical NLP (built on healthcare-trained small language models) to extract, normalize, and structure information from unstructured and structured hospital EHR data into OMOP Common Data Model format. Hospitals retain full data custody while gaining access to multi-site research, quality benchmarking, and pre-built longitudinal Real-World Data assets across oncology, cardiology, and mental health for life sciences customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 48.6% relative increase in genetic testing for rare diseases (hATTR) through AI-driven symptom detection
+4 more records
Product overview1 text field

LynxCare offers a unified clinical data platform built around a federated architecture. The core product is the LynxCare Clinical Data Platform, which integrates three key components: the proprietary cNLP Pipeline (for extracting and normalizing clinical concepts from unstructured EHR notes), the Sentinel Data Quality Framework (automated 5-layer QA ensuring regulatory-grade datasets), and a network of European hospitals providing Real-World Data Assets across oncology, cardiology, and mental health. The platform processes both structured EHR fields and unstructured clinical narratives, harmonizing everything into the OMOP Common Data Model. Hospitals retain full data custody; analytics run locally via federated deployment. Supporting services include Feasibility Assessment (pre-study feasibility checks) and Data Partner Onboarding (structured hospital integration into the network). All outputs are designed for regulatory-grade RWE suitable for life sciences research and EU health data ecosystem participation.

Product and service4 records
1LynxCare Clinical Data Platform
CategoryClinical Data Platform / Real-World Evidence Software
Description

A secure, federated clinical data platform enabling hospitals to extract, harmonize, and analyze EHR data using AI and clinical NLP. The platform processes both structured and unstructured hospital data, maps outputs to OMOP CDM, and runs analytics on-prem or in cloud without transferring raw patient data outside hospital custody. Designed for hospitals and life sciences organizations across Europe.

2Real-World Data Assets (Oncology, Cardiology, Mental Health)
CategoryReal-World Data Products
Description

Pre-built, longitudinal EHR-extracted datasets covering therapeutic areas including Immuno-Oncology (5,000+ patients), Lung Cancer (14,000+), Breast Cancer (20,000+), CLL (2,500+), Multiple Myeloma, Heart Failure (44,000+), aTTR-CM (1,500+), and Mental Health (35,000+). Each asset includes defined endpoints, with a substantial proportion NLP-enriched for granular clinical outcomes. Sold to life sciences organizations for real-world evidence generation.

3Feasibility Assessment Service
CategoryProfessional Services
Description

A project risk-minimization service where LynxCare's clinical and data expert team assesses patient counts and data completeness within the European hospital network against client RWE requirements before full study engagement. Targeted at life sciences organizations planning real-world evidence studies.

4Data Partner Onboarding Service
CategoryProfessional Services
Description

A structured six-step process for hospitals joining LynxCare's federated research network: on-prem data access at the HIS level, transformer-based cNLP enrichment, mapping to FHIR/OMOP CDM standards, RWD quality validation via Sentinel, federated analytics setup, and ongoing value-add beyond the raw data asset. Targeted at European hospitals and hospital networks.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMajorTypeImplementation/ SI/ Consulting Partner
Description

Belgian healthcare interoperability solutions company providing integration services. First joint integration at East Limburg Hospital, with projects at AZ Nikolaas and Cliniques de L'Europe. At ZOL Genk, Amaron extracts data from Chipsoft EHR while LynxCare's AI engine converts reports to coded concepts (SNOMED & ICD-10).

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership announced October 2024 to transform real-world data access in Europe. Dedalus is a leading healthcare IT provider.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

EHDEN data partner since August 2020, certified as SME partner. Committed to standardizing data according to OMOP CDM and can provide support in standardization process to other organizations.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Active participant in OHDSI (Observational Health Data Sciences and Informatics) research network. Gold Sponsor of OHDSI Europe Symposium 2025. Contributes to open-source research networks for harmonized health data.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

LynxCare joined the OncoLab consortium in February 2026 to advance cancer research through collaborative research network.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Acquired by Roche for $1.9B, Flatiron Health provides EHR-derived real-world evidence in oncology with deep clinical NLP. Highly comparable to LynxCare's oncology data assets and OMOP-style harmonization, though at much larger scale and US-centric.

TypeDirect peer
Description

Aetion provides regulatory-grade real-world evidence analytics to life sciences, combining structured and unstructured EHR data. Comparable to LynxCare's RWE platform offering for pharma/biotech evidence generation.

TypeDirect peer
Description

Atropos Health turns de-identified EHR data into real-world evidence through its Evidence Platform, including NLP enrichment of clinical notes. Directly comparable to LynxCare's federated RWE + clinical NLP approach for life sciences clients.

TypeDirect peer
Description

Verantos specializes in high-validity real-world evidence using AI/NLP on EHR data, with regulatory-grade outputs. Directly comparable to LynxCare's clinical NLP and regulatory-grade RWE positioning for pharma.

TypeDirect peer
Description

OM1 operates longitudinal real-world data networks across specialty therapeutic areas with AI-enabled phenotype extraction. Comparable to LynxCare's specialty RWE data assets and NLP-driven phenotype extraction.

TypeBroad incumbent
Description

IQVIA is the global leader in RWE and life sciences analytics with massive data assets and pharma relationships. Comparable as a competitor for LynxCare's life sciences RWE business, but at vastly larger scale and broader scope.

7Tempus
TypeBroad incumbent
Description

Tempus combines multi-modal data (clinical, molecular, imaging) with AI to support precision medicine. Comparable to LynxCare in applying NLP/AI to clinical data for life sciences, though with stronger focus on genomics and US footprint.

TypeEmerging player
Description

Datavant focuses on health data connectivity and privacy-preserving record linkage across institutions. Comparable to LynxCare's federated data architecture philosophy, though Datavant emphasizes de-identification/tokenization rather than clinical NLP.

9HealthVerity
TypeEmerging player
Description

HealthVerity provides privacy-preserving linkage of disparate healthcare data sources for RWE generation. Comparable to LynxCare's federated approach to multi-source clinical data assembly, though with a more US-centric and claims-heavy orientation.

TypeEmerging player
Description

Truveta aggregates de-identified EHR data from a US health system consortium using a common data model for regulatory-grade RWE. Comparable to LynxCare's consortium-based, OMOP-CDM-aligned RWE model, though geographically distinct (US vs EU).

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LynxCare

Healthcare Data Analytics / Real-World Evidence Platformlynx.care

LynxCare operates a federated clinical data platform that uses proprietary NLP to convert European hospital EHRs into OMOP-compliant, quality-validated real-world evidence. It serves hospitals seeking research participation and life sciences organizations requiring regulatory-grade datasets across oncology, cardiology, and mental health.

What LynxCare does

LynxCare Clinical Informatics NV is a Belgian-headquartered health-data company founded in 2015 that operates a federated clinical data platform purpose-built for hospitals and life sciences organizations. Its core technology combines a proprietary clinical Natural Language Processing (cNLP) pipeline — built on healthcare-trained small language models rather than generic LLMs — with OMOP Common Data Model harmonization and a federated-by-design architecture in which analytics and model execution occur where the patient data resides, ensuring hospitals retain custody of raw data and that the system is GDPR-compliant by default. The platform extracts structured, analysis-ready clinical concepts (diagnoses, symptoms, procedures, medications, outcomes) from unstructured EHR narrative text, complements this with structured-field processing, and subjects outputs to a five-layer Sentinel data quality framework (conformance, completeness, plausibility, medical review, benchmark). External validation has demonstrated 94% precision and 88% recall on cancer registry data, outperforming QuickUMLS, Mistral 7B, and SapBERT on multilingual clinical narratives.

The commercial offering is built around pre-built longitudinal real-world data assets spanning oncology, cardiology, and mental health — covering 124,500+ patients across Immuno-Oncology (5,000+), Lung Cancer (14,000+), Breast Cancer (20,000+), CLL (2,500+), Multiple Myeloma (2,500+), Heart Failure (44,000+), aTTR-CM (1,500+), and Mental Health (35,000+) — with 45–80% of endpoints NLP-enriched. Supporting services include feasibility assessments for prospective RWE studies and a structured six-step data partner onboarding process for new hospitals. The company serves two primary customer segments: hospitals seeking to participate in multi-center research, improve quality control, and unlock value from their EHR data; and life sciences organizations (pharma, biotech, medical device companies) needing regulatory-grade real-world evidence for clinical development, regulatory submissions, and post-market surveillance. Go-to-market is enterprise field sales with a quote-based, multi-year subscription model, active across Belgium, the Netherlands, France, and Germany, with an October 2024 partnership with Dedalus extending channel reach and a February 2026 entry into the OncoLab consortium deepening oncology research positioning.

LynxCare has raised approximately €26M cumulatively across multiple funding rounds, with the €20M Series A in June 2022 (led by MTIP, joined by Elaia, Heran Partners, Btov Partners, and PMV) being the largest Belgian digital health round at the time. The company employs 30+ multidisciplinary staff and is led by CEO Mikaela Bruhammar, Co-founder and CMO Dries Hens, CTPO Tom Dufour, with CCO Rhiannon Thomason (Jan 2026), General Counsel Bram Van Eeckhout, and former Sanofi CSO Laurent van Lerberghe as board advisor (Feb 2024). Its compliance stack includes ISO/IEC 27001:2022, NEN 7510, GDPR with appointed DPO, HIPAA, and EHDEN Certified SME Partner status.

LynxCare firmographics

Firmographics
Name
LynxCare
Legal name
LynxCare Clinical Informatics NV
Website
https://lynx.care
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
LynxCare operates a federated clinical data platform that uses proprietary NLP to convert European hospital EHRs into OMOP-compliant, quality-validated real-world evidence. It serves hospitals seeking research participation and life sciences organizations requiring regulatory-grade datasets across oncology, cardiology, and mental health.
Ownership category
akta.pro rank

LynxCare industry classification

Industry
Product category
Healthcare Data Analytics / Real-World Evidence Platform
NAICS
Services for the Elderly and Persons with Disabilities (624120)
SIC
Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLACAIAF
Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACABAJ
Terminology Services & Semantic Interoperability (SNOMED/LOINC/RxNorm mapping)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLAJAJAM
Data Governance, Standards & Interoperability (ICD, HL7/FHIR, LOINC, SNOMED)
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics
SECONDARYHLACAIAH
Clinical Data Repositories (CDR) & Longitudinal Patient Records
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance

Keywords

  • Clinical data platform
  • Real-world evidence
  • Clinical NLP
  • Federated analytics
  • EHR data harmonization

Where LynxCare is headquartered

Location

Headquarters

HQ city
Leuven
HQ country
Belgium
HQ region
Europe

Offices2 records

Markets served

LynxCare business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Real-World Evidence Platform Services: Provides clinical NLP-enriched EHR data, federated analytics, and data quality services to hospitals and life sciences organizations. Revenue likely derived from subscription-based contracts with healthcare organizations for access to the data platform and insights.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise subscription contracts

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

LynxCare product offering

Product offering

Core offering

LynxCare provides a federated clinical data platform that uses proprietary clinical NLP (built on healthcare-trained small language models) to extract, normalize, and structure information from unstructured and structured hospital EHR data into OMOP Common Data Model format. Hospitals retain full data custody while gaining access to multi-site research, quality benchmarking, and pre-built longitudinal Real-World Data assets across oncology, cardiology, and mental health for life sciences customers.

Product overview

LynxCare offers a unified clinical data platform built around a federated architecture. The core product is the LynxCare Clinical Data Platform, which integrates three key components: the proprietary cNLP Pipeline (for extracting and normalizing clinical concepts from unstructured EHR notes), the Sentinel Data Quality Framework (automated 5-layer QA ensuring regulatory-grade datasets), and a network of European hospitals providing Real-World Data Assets across oncology, cardiology, and mental health. The platform processes both structured EHR fields and unstructured clinical narratives, harmonizing everything into the OMOP Common Data Model. Hospitals retain full data custody; analytics run locally via federated deployment. Supporting services include Feasibility Assessment (pre-study feasibility checks) and Data Partner Onboarding (structured hospital integration into the network). All outputs are designed for regulatory-grade RWE suitable for life sciences research and EU health data ecosystem participation.

Differentiator

Problem solved

Functional benefit

Products and services

  • LynxCare Clinical Data Platform A secure, federated clinical data platform enabling hospitals to extract, harmonize, and analyze EHR data using AI and clinical NLP. The platform processes both structured and unstructured hospital data, maps outputs to OMOP CDM, and runs analytics on-prem or in cloud without transferring raw patient data outside hospital custody. Designed for hospitals and life sciences organizations across Europe.
  • Real-World Data Assets (Oncology, Cardiology, Mental Health) Pre-built, longitudinal EHR-extracted datasets covering therapeutic areas including Immuno-Oncology (5,000+ patients), Lung Cancer (14,000+), Breast Cancer (20,000+), CLL (2,500+), Multiple Myeloma, Heart Failure (44,000+), aTTR-CM (1,500+), and Mental Health (35,000+). Each asset includes defined endpoints, with a substantial proportion NLP-enriched for granular clinical outcomes. Sold to life sciences organizations for real-world evidence generation.
  • Feasibility Assessment Service A project risk-minimization service where LynxCare's clinical and data expert team assesses patient counts and data completeness within the European hospital network against client RWE requirements before full study engagement. Targeted at life sciences organizations planning real-world evidence studies.
  • Data Partner Onboarding Service A structured six-step process for hospitals joining LynxCare's federated research network: on-prem data access at the HIS level, transformer-based cNLP enrichment, mapping to FHIR/OMOP CDM standards, RWD quality validation via Sentinel, federated analytics setup, and ongoing value-add beyond the raw data asset. Targeted at European hospitals and hospital networks.

Quantifiable outcome

  • 48.6% relative increase in genetic testing for rare diseases (hATTR) through AI-driven symptom detection
  • +4 more outcomes

Companies that use LynxCare

Customer profile

Named customers6 records

Segments2 records

Ideal customer profiles2 records

LynxCare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

LynxCare partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered major.

  • AmaronmajorImplementation/ SI/ Consulting PartnerBelgian healthcare interoperability solutions company providing integration services. First joint integration at East Limburg Hospital, with projects at AZ Nikolaas and Cliniques de L'Europe. At ZOL Genk, Amaron extracts data from Chipsoft EHR while LynxCare's AI engine converts reports to coded concepts (SNOMED & ICD-10).
  • DedalusmajorStrategic or Co-development PartnerPartnership announced October 2024 to transform real-world data access in Europe. Dedalus is a leading healthcare IT provider.
  • EHDEN (European Health Data and Evidence Network)majorStrategic or Co-development PartnerEHDEN data partner since August 2020, certified as SME partner. Committed to standardizing data according to OMOP CDM and can provide support in standardization process to other organizations.
  • OHDSImajorStrategic or Co-development PartnerActive participant in OHDSI (Observational Health Data Sciences and Informatics) research network. Gold Sponsor of OHDSI Europe Symposium 2025. Contributes to open-source research networks for harmonized health data.
  • OncoLab ConsortiummajorStrategic or Co-development PartnerLynxCare joined the OncoLab consortium in February 2026 to advance cancer research through collaborative research network.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

LynxCare competitors and assessment

Company assessment

Direct peers

  • Flatiron Health: Acquired by Roche for $1.9B, Flatiron Health provides EHR-derived real-world evidence in oncology with deep clinical NLP. Highly comparable to LynxCare's oncology data assets and OMOP-style harmonization, though at much larger scale and US-centric.
  • Aetion: Aetion provides regulatory-grade real-world evidence analytics to life sciences, combining structured and unstructured EHR data. Comparable to LynxCare's RWE platform offering for pharma/biotech evidence generation.
  • Atropos Health: Atropos Health turns de-identified EHR data into real-world evidence through its Evidence Platform, including NLP enrichment of clinical notes. Directly comparable to LynxCare's federated RWE + clinical NLP approach for life sciences clients.
  • Verantos: Verantos specializes in high-validity real-world evidence using AI/NLP on EHR data, with regulatory-grade outputs. Directly comparable to LynxCare's clinical NLP and regulatory-grade RWE positioning for pharma.
  • OM1: OM1 operates longitudinal real-world data networks across specialty therapeutic areas with AI-enabled phenotype extraction. Comparable to LynxCare's specialty RWE data assets and NLP-driven phenotype extraction.

Broad incumbents

  • IQVIA: IQVIA is the global leader in RWE and life sciences analytics with massive data assets and pharma relationships. Comparable as a competitor for LynxCare's life sciences RWE business, but at vastly larger scale and broader scope.
  • Tempus: Tempus combines multi-modal data (clinical, molecular, imaging) with AI to support precision medicine. Comparable to LynxCare in applying NLP/AI to clinical data for life sciences, though with stronger focus on genomics and US footprint.

Emerging players

  • Datavant: Datavant focuses on health data connectivity and privacy-preserving record linkage across institutions. Comparable to LynxCare's federated data architecture philosophy, though Datavant emphasizes de-identification/tokenization rather than clinical NLP.
  • HealthVerity: HealthVerity provides privacy-preserving linkage of disparate healthcare data sources for RWE generation. Comparable to LynxCare's federated approach to multi-source clinical data assembly, though with a more US-centric and claims-heavy orientation.
  • Truveta: Truveta aggregates de-identified EHR data from a US health system consortium using a common data model for regulatory-grade RWE. Comparable to LynxCare's consortium-based, OMOP-CDM-aligned RWE model, though geographically distinct (US vs EU).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

LynxCare social profiles

Digital presence

LynxCare compliance and trust

Trust signal

Compliance5 records

LynxCare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LynxCare leadership team

Management profile

Number of profiles

Profiles6 records

LynxCare funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LynxCare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LynxCare

What does LynxCare do?

LynxCare provides a federated clinical data platform that uses proprietary clinical NLP (built on healthcare-trained small language models) to extract, normalize, and structure information from unstructured and structured hospital EHR data into OMOP Common Data Model format. Hospitals retain full data custody while gaining access to multi-site research, quality benchmarking, and pre-built longitudinal Real-World Data assets across oncology, cardiology, and mental health for life sciences customers.

Is LynxCare a public or private company?

LynxCare is a private company. It is classified as venture growth investor backed and is currently operating.

When was LynxCare founded?

LynxCare was founded in 2015. It employs 11 to 50 people.

Where is LynxCare based?

LynxCare is headquartered in Leuven, Belgium, in the Europe region.

How does LynxCare make money?

One revenue line is on record: real-World Evidence Platform Services.

Who are LynxCare's main competitors?

Direct peers on record are Flatiron Health, Aetion, Atropos Health, Verantos and OM1. Broad incumbents are IQVIA and Tempus. Emerging players are Datavant, HealthVerity and Truveta.

Does LynxCare have an API?

No public API is recorded for LynxCare.

What industry is LynxCare in?

LynxCare's product category is Healthcare Data Analytics / Real-World Evidence Platform. Its primary akta.pro industry code is HLACAIAF, Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm), with a secondary code of HLACABAJ, Terminology Services & Semantic Interoperability (SNOMED/LOINC/RxNorm mapping). Its NAICS code is 624120 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Dealroom.coHolland Capital backs LynxCare to scale its European hospital network | Dealroom NewsLynxCare raised a capital increase led by Holland Capital, with participation from Elaia, HERAN Partners, b2venture, Matterwave Ventures, MTIP, and Vassoyan Conseil. The undisclosed funding will scale its European hospital network and develop clinical language models for oncology. The company has delivered over a dozen real-world evidence studies and is a finalist for the Prix Galien Bridges 2026.GlobeNewswireHealthcare Data Annotation Tools Research Report 2023: A Global $900+ Million Market by 2030 Featuring Infosys, Shaip, Innodata, Ango AI, Capestart, Lynxcare, iMerit, Anolytics, V7, & SuperAnnotateThe global healthcare data annotation tools market is projected to reach $916.8 million by 2030, growing at a 27.5% CAGR from 2023 to 2030. The image/video segment held the largest revenue share at 60.4% in 2022, and North America led with 43.84%.Tech.euBelgian health tech Lynxcare unlocks €20 million to boost clinical insights for doctorsBelgian health tech company LynxCare has raised €20 million in Series A funding led by MTIP to accelerate the international rollout of its AI-powered clinical data platform. The investment aims to help hospitals unlock unused legacy data to improve patient outcomes and clinical insights for doctors. Additionally, LynxCare has partnered with PSIH Group, granting access to its software for 66% of French hospital groups.Computable.beLynxcare trekt groeikapitaal aan voor de VSLynxcare, a Leuven-based medical software startup, raised €1.2 million in funding from banks, venture funds, and government agencies. The company will open a San Francisco office and currently serves five Flemish hospitals, with plans to add three more. It targets €600,000–€800,000 in revenue this year.